image 110
  • Weight Loss
  • In Stock

Zepbound®

Tirzepatide (GLP-1/GIP) Pen

FDA-Approved for Weight Loss. The ultimate dual-action pen.

  • The Powerhouse: The only FDA-approved brand name GLP-1/GIP specifically for weight loss.

  • The Convenience: Pre-filled, single-dose auto-injector. Just uncap and click.

  • How It Works: Targets two hormone receptors to maximize weight loss (up to 20% in clinical trials).

  • The Routine: A convenient, disposable weekly pen.

Annually Quarterly Monthly
$-  $- $1,399

Paid in full, shipped monthly with subscription plans..

Get Started
×

Dosing, Pricing, Shipping

  • Clinician-Led Dosing: Your provider prescribes your exact dose based on your goals.

  • Flat-Rate Pricing: The price is the same for every dose. Save more with annual plans.

  • Monthly Refresh: Ships every 30 days to guarantee freshness and allow for dose adjustments.

Potential Benefits
Prescription appetite suppression:
Zepbound® uses the advanced "dual-agonist" Tirzepatide to target both GLP-1 and GIP hormones. This double-action approach provides superior appetite control, helping to silence cravings more effectively than single-hormone options.

Scientifically backed weight loss:
Zepbound® is the first and only FDA-approved treatment that activates two incretin hormone receptors. In clinical studies, patients taking Zepbound® lost an average of 20% of their body weight, making it the most effective weight loss medication on the market.

Metabolic health booster:
Beyond weight on the scale, Zepbound® improves how your body processes sugar and fat. The GIP component works synergistically with GLP-1 to improve insulin sensitivity and metabolic markers, supporting long-term health.

Enhanced quality of life:
Zepbound® comes in an easy-to-use, single-dose pen. There is no dialing or measuring—the pen is pre-set to your exact dose. This simplicity reduces the mental load of treatment and makes sticking to your weekly routine effortless.
Order Fulfillment

A licensed provider will review your medical intake within 48 hours. You will then be prompted to schedule a visit with the provider.

Processing can take 2 – 10 business days (subject to pharmacy partners).

Once ready, shipping is via 2-day.

Disclaimer

This product is prescribed by a licensed healthcare provider based on the individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. This information is provided for educational purposes only and should not be considered medical advice.

Frequently Asked Questions

Zepbound® is the brand-name version of Tirzepatide, manufactured by Eli Lilly. It is FDA-approved specifically for chronic weight management in adults with obesity or overweight. It is the first medication to target both GLP-1 and GIP receptors.
Zepbound® is the official brand-name product manufactured by Eli Lilly. It is delivered via a "single-dose" auto-injector pen (you use a new pen every week). Compounded Tirzepatide typically comes in a vial and requires a syringe.
The Zepbound® pen is an "auto-injector." You simply place the pen against your skin, unlock it, and press the button. The needle automatically inserts and retracts.
Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. However, clinical trials suggest that the dual-action formula may be better tolerated by some patients compared to single-hormone treatments. Symptoms usually subside as your body adjusts.
Store your Zepbound® pens in the refrigerator (36°F to 46°F). You may store a pen at room temperature (up to 86°F) for up to 21 days if needed, but it should not be returned to the refrigerator after warming up. Do not freeze.
Zepbound® is not recommended for patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also not recommended if you are pregnant, breastfeeding, or have a history of pancreatitis.
Because Zepbound® is FDA-approved specifically for weight loss, some commercial insurance plans with "anti-obesity" benefits may cover it. However, coverage is not guaranteed. We recommend checking your formulary to see if weight loss medications are included.
Yes. Transparency is key to safe medical care. We recommend sharing your Vivoro treatment plan with your primary care physician to ensure all your providers are aligned on your health goals.